Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

Media coverage

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Morningstar.com
  Country/Territory	United States
  Date	4/10/21
  URL	https://www.morningstar.com/news/globe-newswire/8336315/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundations-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepatitis-nash
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	4/10/21
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	4/10/21
  URL	https://www.biospace.com/article/releases/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundation-s-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepatitis-nash-/?s=95
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Yahoo! News
  Country/Territory	United States
  Date	4/10/21
  URL	https://www.yahoo.com/now/madrigal-pharmaceuticals-announces-support-fatty-105000679.html
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	ADVFN UK
  Country/Territory	United Kingdom
  Date	4/10/21
  URL	https://uk.advfn.com/stock-market/NASDAQ/MDGL/share-news/Madrigal-Pharmaceuticals-Announces-Support-of-Fatt/86202517
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Yahoo! Canada
  Country/Territory	Canada
  Date	4/10/21
  URL	https://ca.sports.yahoo.com/news/madrigal-pharmaceuticals-announces-support-fatty-105000679.html
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Yahoo! Finanzas
  Country/Territory	United States
  Date	4/10/21
  URL	https://es-us.finanzas.yahoo.com/news/madrigal-pharmaceuticals-announces-support-fatty-105000679.html
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Chase
  Country/Territory	United States
  Date	4/10/21
  URL	https://idc.chase.com/newspublic/story?article=233790e27069253b&controller=newspublic&action=search&module=default
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis
  Media name/outlet	TD Ameritrade
  Country/Territory	United States
  Date	4/10/21
  URL	https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-277u0231
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Market Newsdesk
  Country/Territory	United States
  Date	4/10/21
  URL	https://www.marketnewsdesk.com/index.php/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundations-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepa/
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation ’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Stockwatch
  Country/Territory	Canada
  Date	4/10/21
  URL	www.stockwatch.com/News/Item/U-z8336315-U!MDGL-20211004/U/MDGL
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	ADVFN US
  Country/Territory	United States
  Date	4/10/21
  URL	https://www.advfn.com/p.php?pid=nmona&article=86202517
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Crwe World
  Country/Territory	United States
  Date	4/10/21
  URL	crweworld.com/article/news-provided-by-globenewswire/2149602/madrigal-pharmaceuticals-announces-support-of-fatty-liver-foundations-screening-fund-to-improve-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-and-non-alcoholic-steatohepatitis-nash
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	WVB
  Country/Territory	United States
  Date	4/10/21
  URL	wvb.com/news/industry/view/id/10236325
  Persons	Meena Bansal

• Title	Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steatohepatitis (NASH)
  Media name/outlet	Market News Publishing
  Country/Territory	United States
  Date	4/10/21
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	GlobeNewswire
  Country/Territory	United States
  Date	4/10/21
  URL	https://www.globenewswire.com/news-release/2021/10/04/2307718/0/en/Madrigal-Pharmaceuticals-Announces-Support-of-Fatty-Liver-Foundation-s-Screening-Fund-to-Improve-Diagnosis-and-Staging-of-Non-Alcoholic-Fatty-Liver-Disease-NAFLD-and-Non-Alcoholic-.html
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
  Media name/outlet	BizWire Express
  Country/Territory	India
  Date	4/10/21
  URL	www.bizwireexpress.com/showstoryGNW.php?storyid=266091
  Persons	Meena Bansal

• Title	Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH); In recognition of Liver Awareness Month, Madrigal
  Media name/outlet	PrimeNewswire (Top News)
  Country/Territory	United States
  Date	4/10/21
  Persons	Meena Bansal